Home › Depression › NCT07673380

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Have a history of opioid and/or stimulant use
* Identify as Black and/or African American
* Seek treatment at local substance use treatment centers
* Fluent in English
* U.S. resident
* 18 years of age or older at the time of data collection.

Exclusion Criteria:

* Self-reported cognitive impairment that would limit ability to participate in research.

About the study

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.

What is being tested

• uMAT-R + enhanced community engagement (behavioral)
• Original uMAT-R supplementary mHealth recovery intervention (behavioral)

Sponsor: Washington University School of Medicine · Participants: 300 · Started: Aug 31, 2025

Contact the study team

• Hannah Szlyk · Phone: 917-836-4225

Official record on ClinicalTrials.gov — NCT07673380

Locations in the U.S.

Conditions

• Depression
• Anxiety

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.